Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
3 hedge funds and large institutions have $5K invested in Adial Pharmaceuticals Warrant in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
29% less capital invested
Capital invested by funds: $7K → $5K (-$2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.72K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$988 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$378 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3K | +$1.72K | +5,015 | +46% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$988 | +2,885 | +44% |
|
|
WAM
3
Wolverine Asset Management
Chicago,
Illinois
| – | +$378 | +1,104 | +552% |
|
ADILW Hedge Fund Activity: Q2 2019 in Review
3 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q2 2019, worth a combined $5K — down 29% from $7K a quarter earlier.
Fund positioning in ADILW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1.72K.
- 3 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $5K of Adial Pharmaceuticals Warrant stock for Q2 2019, down 29% quarter-over-quarter.
- 0 funds opened new Adial Pharmaceuticals Warrant positions in Q2 2019 and 0 closed out.
- The largest Adial Pharmaceuticals Warrant buyer in Q2 2019 was Susquehanna International Group, an estimated $1.72K added.
Based on aggregated 13F filings for Q2 2019.